Condition
Heart Valve Prosthesis
Total Trials
6
Recruiting
0
Active
0
Completed
1
Success Rate
50.0%-37% vs avg
Key Insights
Highlights
Success Rate
50% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 60/100
Termination Rate
16.7%
1 terminated out of 6 trials
Success Rate
50.0%
-36.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
100%
1 of 1 completed with results
Key Signals
1 with results50% success
Data Visualizations
Phase Distribution
4Total
Not Applicable (2)
P 2 (2)
Trial Status
Unknown3
Suspended1
Terminated1
Completed1
Trial Success Rate
50.0%
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (6)
Showing 6 of 6 trials
NCT07610174Phase 2Completed
Effects of Dapagliflozin, Semaglutide, and Their Combination in Heart Failure Patients With Prosthetic Heart Valves
NCT05986396UnknownPrimary
Outcomes of Pulmonary Valve Replacement With the INSPIRIS (Model 11500A) Valve
NCT03965065Not ApplicableUnknownPrimary
Comparison of Sutureless Vs. Standard Biological Prostheses for Surgical Aortic Valve Replacement
NCT03797534Not ApplicableUnknownPrimary
Individualized Administration of Warfarin by Polymorphisms of VKORC1 and CYP2C9 Genes
NCT01505881Phase 2Terminated
Follow on Study From RE-ALIGN
NCT01042067Suspended
Safer Warfarin Treatment
Showing all 6 trials